Human carbonyl reduction pathways and a strategy for their study in vitro

Area of Science:

• Biochemistry
• Pharmacology
• Drug Metabolism

Background:

• Carbonyl reduction is vital in endogenous metabolism, but its role in xenobiotic metabolism by carbonyl-reducing enzymes is less understood.
• Humans possess multiple pathways to metabolize xenobiotic carbonyls into alcohols for excretion.
• Understanding these pathways is critical for drug development and assessing drug clearance.

Purpose of the Study:

• To provide an overview of carbonyl-reducing enzymes involved in xenobiotic metabolism.
• To present an experimental strategy for studying these enzymes in vitro.
• To highlight methods for assessing enzyme contributions in drug development.

Main Methods:

• Review of known carbonyl-reducing enzymes, their properties, and kinetic data.
• Discussion of experimental approaches to assess enzyme contributions, including varying pH and using inhibitors.
• Emphasis on utilizing commercially available reagents for in vitro studies due to limited availability of purified enzymes.

Main Results:

• Individual carbonyl-reducing enzyme isoforms are not widely available.
• Despite limitations, simple experiments with common reagents can elucidate enzyme roles.
• Kinetic data for substrates and inhibitors are provided for key enzymes.

Conclusions:

• Carbonyl-reducing enzymes are important in xenobiotic metabolism and drug clearance.
• An accessible experimental strategy is presented for studying these enzymes in vitro.
• This research aids in understanding and optimizing drug development processes.